ClinicalTrials.Veeva

Menu

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (ISICA-13)

R

Region Skane

Status

Completed

Conditions

Dermatitis, Allergic Contact

Treatments

Behavioral: extended information

Study type

Interventional

Funder types

Other

Identifiers

NCT01953380
ISICA-13

Details and patient eligibility

About

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Enrollment

400 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with suspected contact allergy
  • Age above 18 years
  • Participants have given informed consent

Exclusion criteria

  • Mental or language disabilities

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

400 participants in 2 patient groups

extended information
Active Comparator group
Description:
Extended information on specific allergy
Treatment:
Behavioral: extended information
Information according to clin. routine
No Intervention group
Description:
Information according to clinical routine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems